Ayesha Bryant, MSPH, MD, is a physician, clinical scientist, and associate professor passionate about bridging medical science and everyday health
Breaking down the data To illustrate how orforglipron fits within the landscape of current and emerging therapies, the following table highlights key endpoints from separate trials
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Funding This work was supported by grants from the National Natural Science Foundation (81972259, 82273394), the Clinical Trials Fund from Nanjing Drum Tower Hospital and the Affiliated Hospital of Nanjing University Medical School (2024-LCYJ-PY-01), Suzhou Municipal Health Commission (SKYD2022034), and the discipline construction and support project (XKTJ-JD202006) of the Second Affiliated Hospital of Soochow University
Many patients experience a noticeable reduction in appetite and fewer cravings, making it easier to make mindful, consistent choices around food
Polycystic ovary syndrome (PCOS) is a chronic condition that affects a womans hormones and metabolism in a big way